Adoptive Cell Therapy (Oslo University Hospital)

过继细胞疗法（奥斯陆大学）

Report date: 2022/07/04 19:38:02

Base Information

Drug NameAdoptive Cell Therapy (Oslo University Hospital)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > TCR therapyCell and gene therapy > Gene therapy > mRNA

Mechanisms of ActionGene transferenceTransforming growth factor beta receptor 2 modulators

TargetsTransforming growth factor beta receptor 2

Therapy Area/IndicationsColorectal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNorway

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesOslo University Hospital

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesOslo University Hospital

Active IndicationsN/A

Inactive IndicationsColorectal Neoplasms

Other Information

ATC CodeN/A